MarketBeat Instant News Alerts 2 hours agoJPMorgan China Growth & Income (LON:JCGI) Releases Earnings ResultsMarketBeatJPMorgan China Growth & Income (LON:JCGI - Get Free Report) announced its earnings results on Monday. The company reported GBX 0.14 ($0.00) EPS for the quarter. JPMorgan China Growth & Income had a return on equity of 2.99% and a net margin of 72.25%. LON:JCGIRead JPMorgan China Growth & Income (LON:JCGI) Releases Earnings Results2 hours agoHumana (NYSE:HUM) Updates FY 2025 Earnings GuidanceMarketBeatHumana (NYSE:HUM) updated its FY 2025 earnings guidance. The company provided EPS guidance of 16.250-16.250 for the period, compared to the consensus estimate of 16.350. NYSE:HUMRead Humana (NYSE:HUM) Updates FY 2025 Earnings Guidance2 hours agoCampbell's (NASDAQ:CPB) Issues FY 2025 Earnings GuidanceMarketBeatCampbell's (NASDAQ:CPB) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.950-2.950 for the period, compared to the consensus estimate of 2.980. The company also issued revenue guidance of $10.2 billionillion-$10.4 billionillion, compared to the consensus estimate of $10.3 billionillion. NASDAQ:CPBRead Campbell's (NASDAQ:CPB) Issues FY 2025 Earnings Guidance2 hours agoScience Applications International (NYSE:SAIC) Releases FY 2026 Earnings GuidanceMarketBeatScience Applications International (NYSE:SAIC) updated its FY 2026 earnings guidance. The company provided EPS guidance of 9.100-9.300 for the period, compared to the consensus estimate of 10.240. The company also issued revenue guidance of $7.6 billionillion-$7.8 billionillion, compared to the consensus estimate of $7.9 billionillion. NYSE:SAICRead Science Applications International (NYSE:SAIC) Releases FY 2026 Earnings Guidance2 hours agoCouchbase (NASDAQ:BASE) Given "Buy" Rating at Rosenblatt SecuritiesMarketBeatRosenblatt Securities restated a "buy" rating and issued a $20.00 price objective on shares of Couchbase in a research report on Monday.NASDAQ:BASERead Couchbase (NASDAQ:BASE) Given "Buy" Rating at Rosenblatt Securities2 hours agoCrowdStrike (NASDAQ:CRWD) Stock Price Expected to Rise, Rosenblatt Securities Analyst SaysMarketBeatRosenblatt Securities raised their price objective on CrowdStrike from $450.00 to $515.00 and gave the company a "buy" rating in a research report on Monday.NASDAQ:CRWDRead CrowdStrike (NASDAQ:CRWD) Stock Price Expected to Rise, Rosenblatt Securities Analyst Says Trending News1Lucid Group (NASDAQ:LCID) Shares Down 2.5% - Time to Sell?2Insider Selling: Rolls-Royce Holdings plc (LON:RR) Insider Sells 9,891 Shares of Stock3Tempus AI (NASDAQ:TEM) Shares Gap Down - Should You Sell?4Intel (NASDAQ:INTC) Trading Down 2.2% - Time to Sell?5Wolfspeed (NYSE:WOLF) Trading Down 3% - Time to Sell?6CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) Trading 2.6% Higher - What's Next?7Newsmax (NYSE:NMAX) Trading Down 3.8% - Time to Sell?8Quantum Computing (NASDAQ:QUBT) Shares Gap Down - Should You Sell? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoAffirm (NASDAQ:AFRM) Coverage Initiated by Analysts at Truist FinancialMarketBeatNASDAQ:AFRMRead Affirm (NASDAQ:AFRM) Coverage Initiated by Analysts at Truist Financial2 hours agoBank of America Forecasts Strong Price Appreciation for Amazon.com (NASDAQ:AMZN) StockMarketBeatNASDAQ:AMZNRead Bank of America Forecasts Strong Price Appreciation for Amazon.com (NASDAQ:AMZN) Stock2 hours agoCardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC WainwrightMarketBeatNASDAQ:CRDLRead Cardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC Wainwright2 hours agoThe Goldman Sachs Group Upgrades ArcBest (NASDAQ:ARCB) to BuyMarketBeatNASDAQ:ARCBRead The Goldman Sachs Group Upgrades ArcBest (NASDAQ:ARCB) to Buy2 hours agoTalbot Financial LLC Has $22.17 Million Stock Holdings in The Goldman Sachs Group, Inc. (NYSE:GS)MarketBeatNYSE:GSRead Talbot Financial LLC Has $22.17 Million Stock Holdings in The Goldman Sachs Group, Inc. (NYSE:GS)2 hours agoDouglas Lane & Associates LLC Acquires 189,503 Shares of The AES Co. (NYSE:AES)MarketBeatNYSE:AESRead Douglas Lane & Associates LLC Acquires 189,503 Shares of The AES Co. (NYSE:AES)2 hours agoTalbot Financial LLC Makes New $4.20 Million Investment in F5, Inc. (NASDAQ:FFIV)MarketBeatNASDAQ:FFIVRead Talbot Financial LLC Makes New $4.20 Million Investment in F5, Inc. (NASDAQ:FFIV)2 hours agoThe Travelers Companies, Inc. (NYSE:TRV) Shares Sold by Talbot Financial LLCMarketBeatNYSE:TRVRead The Travelers Companies, Inc. (NYSE:TRV) Shares Sold by Talbot Financial LLC2 hours agoTalbot Financial LLC Has $13.98 Million Position in The Home Depot, Inc. (NYSE:HD)MarketBeatNYSE:HDRead Talbot Financial LLC Has $13.98 Million Position in The Home Depot, Inc. (NYSE:HD)2 hours agoDouglas Lane & Associates LLC Has $18.89 Million Position in Novartis AG (NYSE:NVS)MarketBeatNYSE:NVSRead Douglas Lane & Associates LLC Has $18.89 Million Position in Novartis AG (NYSE:NVS)2 hours agoDouglas Lane & Associates LLC Has $28.41 Million Stock Position in Zoetis Inc. (NYSE:ZTS)MarketBeatNYSE:ZTSRead Douglas Lane & Associates LLC Has $28.41 Million Stock Position in Zoetis Inc. (NYSE:ZTS)2 hours agoWaste Connections, Inc. (NYSE:WCN) Shares Bought by Douglas Lane & Associates LLCMarketBeatNYSE:WCNRead Waste Connections, Inc. (NYSE:WCN) Shares Bought by Douglas Lane & Associates LLC2 hours agoDouglas Lane & Associates LLC Lowers Holdings in RTX Co. (NYSE:RTX)MarketBeatNYSE:RTXRead Douglas Lane & Associates LLC Lowers Holdings in RTX Co. (NYSE:RTX)2 hours agoThe J. M. Smucker Company (NYSE:SJM) Shares Bought by Douglas Lane & Associates LLCMarketBeatNYSE:SJMRead The J. M. Smucker Company (NYSE:SJM) Shares Bought by Douglas Lane & Associates LLC2 hours agoDouglas Lane & Associates LLC Boosts Stock Position in Teck Resources Limited (NYSE:TECK)MarketBeatNYSE:TECKRead Douglas Lane & Associates LLC Boosts Stock Position in Teck Resources Limited (NYSE:TECK)2 hours agoDouglas Lane & Associates LLC Reduces Position in Illumina, Inc. (NASDAQ:ILMN)MarketBeatNASDAQ:ILMNRead Douglas Lane & Associates LLC Reduces Position in Illumina, Inc. (NASDAQ:ILMN)2 hours agoDouglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)MarketBeatNASDAQ:MRNARead Douglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)2 hours agoDouglas Lane & Associates LLC Reduces Holdings in XPO, Inc. (NYSE:XPO)MarketBeatNYSE:XPORead Douglas Lane & Associates LLC Reduces Holdings in XPO, Inc. (NYSE:XPO)2 hours agoDouglas Lane & Associates LLC Buys 16,615 Shares of The Estée Lauder Companies Inc. (NYSE:EL)MarketBeatNYSE:ELRead Douglas Lane & Associates LLC Buys 16,615 Shares of The Estée Lauder Companies Inc. (NYSE:EL)2 hours agoVulcan Materials (NYSE:VMC) Stake Increased by Douglas Lane & Associates LLCMarketBeatNYSE:VMCRead Vulcan Materials (NYSE:VMC) Stake Increased by Douglas Lane & Associates LLC2 hours agoDouglas Lane & Associates LLC Trims Stake in Ferrari (NYSE:RACE)MarketBeatNYSE:RACERead Douglas Lane & Associates LLC Trims Stake in Ferrari (NYSE:RACE)2 hours agoDouglas Lane & Associates LLC Boosts Stock Position in CVS Health Co. (NYSE:CVS)MarketBeatNYSE:CVSRead Douglas Lane & Associates LLC Boosts Stock Position in CVS Health Co. (NYSE:CVS)2 hours agoDouglas Lane & Associates LLC Purchases 21,095 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)MarketBeatNYSE:ZBHRead Douglas Lane & Associates LLC Purchases 21,095 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)2 hours agoDouglas Lane & Associates LLC Purchases 4,199 Shares of RBC Bearings Incorporated (NYSE:RBC)MarketBeatNYSE:RBCRead Douglas Lane & Associates LLC Purchases 4,199 Shares of RBC Bearings Incorporated (NYSE:RBC) Featured Articles and Offers3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeThe Trump Dump is starting; Get out of stocks now?From Paradigm Press(Ad)View The Trump Dump is starting; Get out of stocks now?Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsLucid Group (NASDAQ:LCID) Shares Down 2.5% - Time to Sell?By MarketBeat | June 1, 2025View Lucid Group (NASDAQ:LCID) Shares Down 2.5% - Time to Sell?Intel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingTrump Exec Order 14179 is wealth “gift” to good Americans?From Paradigm Press(Ad)View Trump Exec Order 14179 is wealth “gift” to good Americans?Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookInsider Selling: Rolls-Royce Holdings plc (LON:RR) Insider Sells 9,891 Shares of StockBy MarketBeat | June 1, 2025View Insider Selling: Rolls-Royce Holdings plc (LON:RR) Insider Sells 9,891 Shares of Stock Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
